πŸ‡ΊπŸ‡Έ FDA
Patent

US 8569380

Oligomer-tricyclic conjugates

granted A61KA61K47/60A61P

Quick answer

US patent 8569380 (Oligomer-tricyclic conjugates) held by Nektar Therapeutics expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K47/60, A61P, A61P25/02, A61P25/08